Aktieanalys

Qlife Q2 2023: Cost reductions completed - Redeye

Redeye Publicerad: 18 Aug 2023 07:56

Qlife has restructured its operations, reducing its workforce considerably and terminating its leasing contract, so the fixed costs will be much lower going forward. It will focus on co-development in medical research and sales of CRP tests with partners. The financial situation is still strained, but the company has cash to continue operations during this year.

Länk till analysen i sin helhet: https://www.redeye.se/research/933385/qlife-q2-2023-cost-reductions-completed?utm_source=finwire&utm_medium=RSS

Nyheter om QLife

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!